Search

everythinglearnresearchcommunity

for

Search:↓

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Finasteride caused enlarged breast tissue in a 62-year-old man.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.

Women with irregular periods should be checked for PCOS and treated early to prevent complications, with birth control pills helping to manage symptoms.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Quercetin may help with PCOS symptoms, but more research is needed.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

Herbal treatments can help manage PCOS symptoms.

Follicle Stimulating Hormone is important for fertility.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

High LH levels cause hair loss by damaging and aging hair follicles.

Low estrogen compared to androgen may cause female hair loss.